Executive Summary
Market Analysis
2.1. Market size and growth rates
2.2. Macroeconomic change
2.3. Market growth drivers, market dynamics and trends
2.4. Megatrends and their impact
2.5. Value chain analysis
2.6. Market scenarios and opportunity forecasts
2.7. Relevant markets
2.8. The new frontiers of growth
2.9. Creating value through sustainable strategies
Sentiment Analysis
3.1. Internal Friction Analysis: Where workflows are failing
3.2. Budgetary Pivot: Spending intent for next 12 months
3.3. Unmet ROI: Where current solutions are failing
3.4. Risk Aversion: Board-level fears regarding adoption
3.5. Legacy Debt: Technology replacement timelines
3.6. Social Proof: Competitive admiration benchmarking
3.7. Future-Skilling: Labor market shifts and obsolescence
3.8. Decision Maker Psychology: Selection vs. Rejection criteria
3.9. Price Elasticity: The "Too Cheap to Trust" floor
3.10.The Unasked Question: Emerging industry blind spots
Market Breakdown by Offering
4.1. Consumables
4.2. Services
4.3. Softwares
Market Breakdown by Type
5.1. Safetly Biomarkers
5.2. Efficacy Biomarkers
5.3. Validation Biomarkers
Market Breakdown by Technology
6.1. PCR
6.2. NGS
6.3. Microarrays
6.4. Genomic Hybridization
6.5. Other Technologies
Market Breakdown by Application
7.1. Cancer
7.2. Infectious Diseases
7.3. Immunological Disorders
7.4. Cardiovascular Disorders
7.5. Other Disease Indication
Market Breakdown by End User
8.1. Hospitals & Diagnostic Laboratories
8.2. Pharmaceutical & Biopharmaceutical Companies
8.3. Academic Institutes & Research Institutes
8.4. Other End Users
Market Breakdown by Geography
9.1. North America
9.1.1. U.S.
9.1.2. Canada
9.1.3. Mexico
9.2. South America
9.2.1. Brazil
9.2.2. Argentina
9.2.3. Others
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. U.K.
9.3.4. Italy
9.3.5. Spain
9.3.6. Sweden
9.3.7. Switzerland
9.3.8. Netherlands
9.3.9. Others
9.4. Asia-Pacific
9.4.1. China
9.4.2. Japan
9.4.3. South Korea
9.4.4. India
9.4.5. Australia
9.4.6. Others
9.5. Middle East & Africa
9.5.1. South Africa
9.5.2. Saudi Arabia
9.5.3. UAE
9.5.4. Israel
9.5.5. Others
Competitive Landscape
10.1.Competitive situation and trends
10.2.Industry benchmarking
10.3.Maintaining current market share
10.4.Expansion path
10.5.Recent market and industry developments
10.5.1.New product developments and announcements
10.5.2.Agreements, partnerships, joint ventures, and collaborations
10.5.3.Mergers and acquisitions and major PE deals
Companies Profiled
11.1.Agilent Technologies, Inc.
11.2.Bio-Rad Laboratories, Inc.
11.3.Danaher Corporation
11.4.Eurofins Scientific
11.5.Exact Sciences Corporation
11.6.F. Hoffmann-La Roche Ltd
11.7.Illumina, Inc.
11.8.Myriad Genetics, Inc.
11.9.QIAGEN N.V.
11.10.Thermo Fisher Scientific